BiomX (PHGE) Institutional Ownership $0.57 -0.16 (-22.19%) Closing price 03:56 PM EasternExtended Trading$0.59 +0.01 (+1.91%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartHeadlinesInsider TradesOwnershipSEC FilingsBuy This Stock Institutional Ownership Changes (13F Filings) for BiomX (NYSEMKT:PHGE)CurrentInstitutional OwnershipPercentage40.57%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$50.94MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$4.45M Get PHGE Insider Trade Alerts Want to know when executives and insiders are buying or selling BiomX stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHGE Institutional Buying and Selling by Quarter BiomX Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Alyeska Investment Group L.P.865,400$632K0.0%N/A4.761% 2/17/2025Allostery Investments LP643,833$470K0.5%N/A3.542% 2/14/2025Heights Capital Management Inc.258,492$189K0.1%-56.1%1.422% 2/14/2025Johnson & Johnson96,866$71K0.0%-49.6%0.533% 2/12/2025JPMorgan Chase & Co.429,990$314K0.0%N/A2.366% 11/19/2024Barclays PLC25,000$26K0.0%-90.0%0.138% 11/15/2024Barclays PLC25,000$26K0.0%-90.0%0.140% 11/15/2024Ikarian Capital LLC893,000$911K0.1%N/A4.990% 11/14/2024Johnson & Johnson192,321$196K0.0%-90.0%1.075% 11/7/20248VC GP I LLC108,621$111K0.2%-90.0%0.607% 5/17/2024Ikarian Capital LLC10,817,327$4.87M0.5%N/A19.590% 5/10/2024Johnson & Johnson1,923,201$865K0.0%-9.9%3.483% 11/3/2022Royce & Associates LP158,655$54K0.0%-51.7%0.529% 5/5/2022Royce & Associates LP320,655$619K0.0%+200.5%1.077% 2/7/2022Royce & Associates LP106,696$171K0.0%-52.7%0.373% 11/12/2021Johnson & Johnson2,133,402$6.53M0.6%N/A7.568% 10/26/2021Taylor Wealth Management Partners40,098$91K0.0%-44.3%0.142% 8/17/2021Millennium Management LLC427,702$2.34M0.0%-5.9%1.758% 8/17/2021Bridgeway Capital Management LLC104,000$568K0.0%-15.4%0.427% 5/18/2021Millennium Management LLC454,377$3.24M0.0%-1.2%1.954% 5/18/2021Jane Street Group LLC25,365$181K0.0%N/A0.109% 5/13/2021Renaissance Technologies LLC36,200$258K0.0%N/A0.156% 5/10/2021Royce & Associates LP359,000$2.56M0.0%N/A1.544% (Data available from 1/1/2016 forward) PHGE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHGE shares? During the previous two years, the following institutional investors and hedge funds held shares of BiomX shares: Ikarian Capital LLC ($911K), Alyeska Investment Group L.P. ($632K), Allostery Investments LP ($470K), JPMorgan Chase & Co. ($314K), Heights Capital Management Inc. ($189K), 8VC GP I LLC ($111K), and Johnson & Johnson ($71K).Learn more on PHGE's institutional investors. What percentage of BiomX stock is owned by institutional investors? 40.57% of BiomX stock is owned by institutional investors. Learn more on PHGE's institutional investor holdings. Which institutional investors have been buying BiomX stock? The following institutional investors have purchased BiomX stock in the last 24 months: Ikarian Capital LLC ($11.71M), Alyeska Investment Group L.P. ($865.40K), Allostery Investments LP ($643.83K), and JPMorgan Chase & Co. ($429.99K). How much institutional buying is happening at BiomX? Institutional investors have bought a total of 13,649,550 shares in the last 24 months. This purchase volume represents approximately $50.94M in transactions. Which BiomX major shareholders have been selling company stock? The following institutional investors have sold BiomX stock in the last 24 months: Johnson & Johnson ($2.04M), 8VC GP I LLC ($977.57K), Barclays PLC ($450K), and Heights Capital Management Inc. ($330.54K). How much institutional selling is happening at BiomX? Institutional investors have sold a total of 3,794,641 shares in the last 24 months. This volume of shares sold represents approximately $4.45M in transactions. Related Companies PDS Biotechnology Major Shareholders Skye Bioscience Major Shareholders Repare Therapeutics Major Shareholders Immix Biopharma Major Shareholders Applied Therapeutics Major Shareholders Armata Pharmaceuticals Major Shareholders Precision BioSciences Major Shareholders Kronos Bio Major Shareholders Karyopharm Therapeutics Major Shareholders Gain Therapeutics Major Shareholders This page (NYSEMKT:PHGE) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiomX Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BiomX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
